Ann: FDA Approves Sofdra, page-483

difference BOT own destiny..NEU sold out..

That is an over-the-top claim and I don't think it is very fair to Neuren, especially considering Neuren's prospects.

You have just witnessed Botanix raise and dilute to get a product launched. How do you think Botanix is going to get the rest of its pipeline completed? Money has to come from somewhere, doesn't it? Internal funding will be massive and a major burden if one of the pipeline fails.

Quite a few of the excitable ones on here were already buying cars, houses and probably new wives upon approval but companies like Botanix and Neuren rarely see a simple progression, you were predicting 60 cents but many of the starry-eyed crew didn't see the raise coming as Botanix apparently had enough money in the bank!

Enjoy both companies if you hold Neuren. I know I do. Botanix and its sweat stopper is a good ride.